Issues & Experts >
Issues & Experts Archive > GM bankruptcy, heroin
GM bankruptcy, heroin
Document Tools
June 1, 2009
GM’s bankruptcy proceedings begin
GM’s bankruptcy will inevitably hurt all of its stakeholders: workers, investors, and communities, says SFU business professor Jerry Sheppard, who specializes in bankruptcies and business restructuring. “Companies that end up where GM is do two wrong things simultaneously; they over-apply or misapply their strategy or business model and they drift from their core business. In GM’s case, its strategy was one of broad differentiation. The company famously used this strategy to take down market leader Ford in the 1920s and become world leader for over 70 years.” Sheppard can share his predictions about GM’s future and what the beleaguered company needs to do.
Jerry Sheppard, 778.782.4918; jerry_sheppard@sfu.ca
Heroin trials don’t harm communities
SFU criminologist Neil Boyd and health scientist Benedikt Fischer are among four Canadian researchers who have found that making heroin available for injection via a secure clinic doesn’t cause increased crime or illicit drug use in the neighbourhoods or communities surrounding the clinic. Boyd and Fischer can expand on why their findings suggest that governments may be able to support heroin prescription clinics without fear that they could destroy or damage the communities in which they are located. Their study is available at http://tinyurl.com/kjsd3p.
Neil Boyd, immediately available at 604.947.9569, 778.782.3324, nboyd@sfu.ca
GM’s bankruptcy will inevitably hurt all of its stakeholders: workers, investors, and communities, says SFU business professor Jerry Sheppard, who specializes in bankruptcies and business restructuring. “Companies that end up where GM is do two wrong things simultaneously; they over-apply or misapply their strategy or business model and they drift from their core business. In GM’s case, its strategy was one of broad differentiation. The company famously used this strategy to take down market leader Ford in the 1920s and become world leader for over 70 years.” Sheppard can share his predictions about GM’s future and what the beleaguered company needs to do.
Jerry Sheppard, 778.782.4918; jerry_sheppard@sfu.ca
Heroin trials don’t harm communities
SFU criminologist Neil Boyd and health scientist Benedikt Fischer are among four Canadian researchers who have found that making heroin available for injection via a secure clinic doesn’t cause increased crime or illicit drug use in the neighbourhoods or communities surrounding the clinic. Boyd and Fischer can expand on why their findings suggest that governments may be able to support heroin prescription clinics without fear that they could destroy or damage the communities in which they are located. Their study is available at http://tinyurl.com/kjsd3p.
Neil Boyd, immediately available at 604.947.9569, 778.782.3324, nboyd@sfu.ca